清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

New Combination of Triamcinolone, 5-Fluorouracil, and Pulsed-Dye Laser for Treatment of Keloid and Hypertrophic Scars

医学 曲安奈德 红斑 疤痕 瘢痕疙瘩 氟尿嘧啶 增生性瘢痕 外科 增生性瘢痕 耐火材料(行星科学) 泌尿科 化疗 物理 天体生物学
作者
Ali Asilian,Afshin Darougheh,FAZLOLAH SHARIATI
出处
期刊:Dermatologic Surgery [Lippincott Williams & Wilkins]
卷期号:32 (7): 907-915 被引量:196
标识
DOI:10.1111/j.1524-4725.2006.32195.x
摘要

BACKGROUND: Keloids and hypertrophic scars are benign growths of dermal collagen that usually cause major physical, psychological, and cosmetic problems. METHODS: In this 12-week single-blinded clinical trial, 69 patients were randomly assigned into three study groups. In Group 1, intralesional triamcinolone acetonide (TAC, 10 mg/mL) was injected at weekly intervals for a total of 8 weeks. In Group 2 [TAC+5-fluorouracil (5-FU)], 0.1 mL of 40 mg/mL TAC was added to 0.9 mL of 5-FU (50 mg/mL). This combination was injected weekly for 8 weeks. In Group 3, in addition to weekly TAC+5-FU injection for 8 weeks, lesions were irradiated by 585-nm flashlamp-pumped pulsed-dye laser (PDL, 5-7.5 J/cm2) at the 1st, 4th, and 8th weeks. Lesions were assessed for erythema, pruritus, pliability, height, length, and width. RESULTS: Sixty patients completed the study. At the 8- and 12-week follow-up visits, all groups showed an acceptable improvement in nearly all measures, but in comparison between groups, these were statistically more significant in the TAC+5-FU and TAC+5-FU+PDL groups (p<.05 for all). At the end of the study, the erythema score was significantly lower, and itch reduction was statistically higher in the TAC+5-FU+PDL group (p<.05 for both). Good to excellent improvements (>50% improvement) were reported by the patients as follows: 20% in Group 1, 55% in Group 2, and 75% in Group 3, all of which were significantly different (p<.05). Good to excellent responses were reported by the blinded observer as follows: 15% in Group 1, 40% in Group 2, and 70% in Group 3. Their differences were statistically significant (p<.05). Atrophy and telangiectasia were seen in 37% of patients in TAC group. CONCLUSION: Overall efficacy of TAC+5-FU was comparable with TAC+5-FU+PDL, but the TAC+5-FU+PDL combination was more acceptable by the patients and produced better results. Its effect on lightening of the lesion was promising. The TAC+5-FU+PDL combination seems to be the best approach for treatment of keloid and hypertrophic scars.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
潇洒醉冬完成签到,获得积分10
1秒前
瘦瘦的涫完成签到,获得积分10
1秒前
Lemenchichi完成签到,获得积分10
3秒前
MassTestA1的应助被MassTestA1采纳,获得50
4秒前
qin202569完成签到,获得积分20
5秒前
宝石发布了新的文献求助10
6秒前
追寻的凌香完成签到,获得积分10
6秒前
20秒前
26秒前
stanfordlee发布了新的文献求助10
26秒前
vbnn完成签到 ,获得积分10
28秒前
热情的梦秋完成签到,获得积分10
43秒前
LINDENG2004完成签到 ,获得积分10
56秒前
隐形的灵薇完成签到,获得积分10
56秒前
仁爱采蓝完成签到,获得积分10
1分钟前
xfy发布了新的文献求助200
1分钟前
Keyh完成签到,获得积分10
1分钟前
1分钟前
优美的烙完成签到,获得积分10
1分钟前
FODCOC完成签到,获得积分10
1分钟前
重要寄瑶完成签到,获得积分10
1分钟前
1分钟前
贪玩的梦容完成签到,获得积分10
1分钟前
amiee发布了新的文献求助30
2分钟前
夏日随笔完成签到 ,获得积分10
2分钟前
火柴盒完成签到,获得积分10
2分钟前
lx完成签到 ,获得积分10
2分钟前
xzx完成签到,获得积分10
2分钟前
专注寒蕾完成签到,获得积分10
2分钟前
2分钟前
2分钟前
stanfordlee完成签到,获得积分10
2分钟前
limengyao完成签到,获得积分10
2分钟前
沉静曼梅完成签到,获得积分10
2分钟前
忧郁的芳完成签到,获得积分10
2分钟前
迷你的蜜粉完成签到,获得积分10
2分钟前
英俊的小懒虫完成签到 ,获得积分10
3分钟前
3分钟前
3分钟前
勤恳寄凡发布了新的文献求助10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185453
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834449
捐赠科研通 7782987
什么是DOI,文献DOI怎么找? 3434570
关于科研通互助平台的介绍 2558881
邀请新用户注册赠送积分活动 2481299